Effects of poloxamer 407-induced hyperlipidemia on hepatic multidrug resistance protein 2 (Mrp2/Abcc2) and the pharmacokinetics of mycophenolic acid in rats-Reference-Cited by-同舟云学术

Effects of poloxamer 407-induced hyperlipidemia on hepatic multidrug resistance protein 2 (Mrp2/Abcc2) and the pharmacokinetics of mycophenolic acid in rats

Published:2016-09 Issue:6 Volume:37 Page:352-365
ISSN:0142-2782
Container-title:Biopharmaceutics & Drug Disposition
language:en
Short-container-title:Biopharm. Drug Dispos.

Author:

Kwon Mi Hye¹,Yoon Ji Na¹,Baek Yu Jin¹,Kim Yu Chul²,Cho Yong Yeon¹,Kang Hee Eun¹

Affiliation:

1. College of Pharmacy and Integrated Research Institute of Pharmaceutical Sciences; The Catholic University of Korea; Bucheon South Korea

2. Discovery Research Center; C&C Research Laboratories; Suwon South Korea

Funder

National Research Foundation (NRF)

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,General Medicine

Reference51 articles.

1. Effects of hyperlipidemia on the pharmacokinetics of nifedipine in the rat;Eliot;Pharm Res,1999

2. The impact of experimental hyperlipidemia on the distribution and metabolism of amiodarone in rat;Shayeganpour;Int J Pharm,2008

3. Pharmacokinetics of amiodarone in hyperlipidemic and simulated high fat-meal rat models;Shayeganpour;Biopharm Drug Dispos,2005

4. Pharmacokinetics of human immunodeficiency virus protease inhibitor, nelfinavir, in poloxamer 407-induced hyperlipidemic model rats;Sugioka;Biol Pharm Bull,2009

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pharmacokinetics of dabigatran in a rat model of hyperlipidemia induced by poloxamer 407;Xenobiotica;2024-09-12

2. Comparative pharmacokinetic investigation on crocetin in hyperlipidemia and normal rats after oral administration;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-02-22

3. The pharmacokinetics of mycophenolic acid in rats with orotic acid induced nonalcoholic fatty liver disease;Canadian Journal of Physiology and Pharmacology;2020-03

4. Medical devices that look like medicines: safety and regulatory concerns for children in Europe;Archives of Disease in Childhood;2019-12-03

5. Effects of UGT1A1 Polymorphism, Gender and Triglyceride on the Pharmacokinetics of Telmisartan in Chinese Patients with Hypertension: A Population Pharmacokinetic Analysis;European Journal of Drug Metabolism and Pharmacokinetics;2019-06-28